Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in the disease

International Immunology

Volumn 21, Issue 8, 2009, Pages 967-975

  Tölgyesi, Gergely ^a   Molnár, Viktor ^a   Semsei, Ágnes F ^a   Kiszel, Petra ^a   Ungvári, Ildikó ^a   Pócza, Péter ^a   Wiener, Zoltán ^a   Komlósi, Zsolt I ^a   Kunos, László ^a   Gálffy, Gabriella ^a   Losonczy, György ^a   Seres, Ildikó ^b   Falus, András ^a   Szalai, Csaba ^a,c,d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^d Csertex Research Laboratory   (Hungary)

Author keywords

Airway inflammation; Gene set enrichment analysis; Microarray; Oxidative stress; Paraoxonase 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; INTERLEUKIN 6; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; OVALBUMIN; TUMOR NECROSIS FACTOR;

ADULT; ALLERGY TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; CELL CYCLE; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EOSINOPHIL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE IDENTIFICATION; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RNA ISOLATION; UPREGULATION;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ASTHMA; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, INBRED BALB C;

EID: 70349514838     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp063     Document Type: Article

References (34)

1. Busse, W. W. and Lemanske, R. F. Jr 2001. Asthma. N. Engl. J. Med. 344:350.
2. Braman, S. S. 2006. The global burden of asthma. Chest 130:4S.
3. Szalai, C., Ungvari, I., Pelyhe, L., Tolgyesi, G. and Falus, A. 2008. Asthma from a pharmacogenomic point of view. Br. J. Pharmacol. 153:1602.
4. Karp, C. L., Grupe, A., Schadt, E. et al. 000. Identification of complement factor 5 as a susceptibility Iocus for experimental allergic asthma. Nat. Immunol. 1:221.
5. Zimmermann, N., King, N. E., Laporte, J. et al. 2003. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Invest. 111:1863.
6. King, N. E., Zimmermann, N., Pope, S. M. et al. 2004. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma. Am. J. Respir. Cell Mol. Biol. 31:257.
7. Zimmermann, N., Doepker, M. P., Witte, D. P. et al. 2005. Expression and regulation of small proline-rich protein 2 in allergic inflammation. Am. J. Respir. Cell Mol. Biol. 32:428.
8. Zhu, Z., Zheng, T., Homer, R. J. et al. 2004. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 304:1678.
9. Zosky, G. R., Larcombe, A. N., White, O. J. et al. 2008. Ovalbumin-sensitized mice are good models for airway hyperresponsiveness but not acute physiological responses to allergen inhalation. Clin. Exp. Allergy 38:829.
10. Komlosi, Z. I., Pozsonyi, E., Tabi, T. et al. 2006. Lipopolysaccha-ride exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS. Clin. Exp. Allergy 36:951.
11. Kozma, G. T., Losonczy, G., Keszei, M. et al. 2003. Histamine deficiency in gene-targeted mice strongly reduces antigen-induced airway hyper-responsiveness, eosinophilia and allergen-specific IgE. Int. Immunol. 15:963.
12. Aviram, M. and Rosenblat, M. 2005. Paraoxonases and cardio-vascular diseases: Pharmacological and nutritional influences. Curr. Opin. Lipidol. 16:393.
13. Fairbairn, S. M., Page, C. P., Lees, P. and Cunningham, F. M. 1993. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clin. Exp. Allergy 23:821.
14. Ohkawara, Y., Lei, X. F., Stampfli, M. R., Marshall, J. S., Xing, Z. and Jordana, M. 1997. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am. J. Respir. Cell Mol. Biol. 16:510.
15. Lewis, C. C., Yang, J. Y., Huang, X. et al. 2008. Disease-specific gene expression profiling in multiple models of lung disease. Am. J. Respir. Crit. Care Med. 177:376.
16. Mackness, M. I., Arrol, S., Abbott, C. and Durrington, P. N. 1993. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atheroscle-rosis 104:129.
17. Rozenberg, O., Shiner, M., Aviram, M. and Hayek, T. 2008. Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties. Free Radic. Biol. Med. 44:1951.
18. Rochelle, L. G., Fischer, B. M. and Adler, K. B. 1998. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic. Biol. Med. 24: 863.
19. Gutteridge, J. M. 1995. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin. Chem. 41:1819.
20. Górnicka, G., Bełtowski, J., Wójcicka, G. and Jamroz, A. 2002. Serum paraoxonase activity, total antioxidant potential and lipid peroxidation products in children with bronchial asthma exacerbation. Wiad. Lek. 55:257.
21. Aviram, M., Rosenblat, M., Billecke, S. et al. 1999. Human serum paraoxonase (PON 1) is inactivated by oxidized Iow density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 26:892.
22. Isik, A., Koca, S. S., Ustundag, B., Celik., H. and Yildirim, A. 2007. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin. Rheumatol. 26:342.
23. Tanimoto, N., Kumon, Y., Suehiro, T. et al. 2003. Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci. 72:2877.
24. van den Berg, S. W., Jansen, E. H., Kruijshoop, M. et al. 2008. Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study). Diabet. Med. 25:186.
25. Gur, M., Aslan, M., Yildiz, A. et al. 2006. Paraoxonase and arylesterase activities in coronary artery disease. Eur. J. Clin. Invest. 36:779.
26. Elkiran, E. T., Mar, N., Aygen, B., Gursu, F., Karaoglu, A. and Koca, S. 2007. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 7:48.
27. Humbert, R., Adler, D. A., Disteche, C. M., Hassett, C., Omiecinski, C. J. and Furlong, C. E. 1993. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3:73.
28. Brophy, V. H., Hastings, M. D., Clendenning, J. B., Richter, R. J., Jarvik, G. P. and Furlong, C. E. 2001. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 11:77.
29. Bhattacharyya, T., Nicholls, S. J., Topol, E. J. et al. 2008. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299:1265.
30. Flekac, M., Skrha, J., Zidkova, K., Lacinova, Z. and Hilgertova, J. 2008. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus. Physiol. Res. 57:717.
31. San Millan, J. L., Corton, M., Villuendas, G., Sancho, J., Peral, B. and Escobar-Morreale, H. F. 2004. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J. Clin. Endocrinol. Metab. 89:2640.
32. Riedl, M. A, and Nel, A. E. 2008. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr. Opin. Allergy Clin. Immunol. 8:49.
33. Shaheen, S. O., Sterne, J. A., Thompson, R. L., Songhurst, C. E., Margetts, B. M. and Burney, P. G. 2001. Dietary antioxidants and asthma in adults: Population-based case-control study. Am. J. Respir. Crit. Care Med. 164:1823.
34. Fuhrman, B. and Aviram, M. 2002. Preservation of paraoxonase activity by wine flavonoids: Possible role in protection of LDL from lipid peroxidation. Ann. N. Y. Acad. Sci. 957:321.